Epilepsy Market to Reach US$ 10.7 Billion by 2030 at 4.1% CAGR
The Dipeptidyl Peptidase-4 Inhibitors Market is expected to reach US$ 14.19 billion by 2034, up from US$ 11.83 billion in 2025, and is estimated to register a CAGR of 2.04% from 2026 to 2034. Dipeptidyl Peptidase-4 Inhibitors are an important …